Circadian rhythm sleep–wake disorders are a group of conditions in which the timing of sleep and wakefulness is persistently or recurrently disturbed because the internal biological clock is altered or is poorly aligned with the external environment. Their characteristic consequences are difficulty sleeping at the required time, excessive sleepiness during required wakefulness, or both, together with clinically significant distress or impairment. Unlike many other sleep disorders, the central problem may be when sleep occurs rather than an inability to produce normal sleep.
The group includes delayed and advanced sleep–wake phase disorders, non-24-hour sleep–wake rhythm disorder, irregular sleep–wake rhythm disorder, shift work disorder, and jet lag disorder. These conditions connect the biology of the circadian rhythm with everyday scheduling, light exposure, visual function, development, aging, and working conditions. Their evaluation therefore depends on sleep patterns across multiple days, not simply on a single night's sleep.
Biological timing and the regulation of sleep
Sleep timing emerges from the interaction of circadian regulation and sleep-dependent homeostasis. In the influential two-process model developed by Alexander Borbély in 1982, homeostatic sleep pressure increases during wakefulness and declines during sleep, while a circadian process changes the propensity for sleep and alertness over approximately 24 hours. The interaction explains why a person can become more alert in the evening despite having been awake all day, and why sleep can end after a short daytime interval even when substantial sleep debt remains.
The principal circadian pacemaker is the suprachiasmatic nucleus, a paired structure in the anterior hypothalamus. Its neurons generate rhythmic activity through molecular feedback loops involving clock-related genes and their protein products. Related clocks occur throughout the body. The central pacemaker helps coordinate these rhythms, while feeding, activity, and other signals also influence peripheral tissues. A sleep–wake schedule can consequently become misaligned not only with environmental time but also with rhythms in temperature, hormone secretion, and metabolic function.
Light is the dominant environmental synchronizer, or zeitgeber, for the human circadian system. Specialized retinal ganglion cells containing the photopigment melanopsin transmit information about environmental illumination to the central clock. Their signaling also incorporates input from rods and cones. Circadian responses depend on the timing, duration, intensity, and spectral composition of light, as well as recent light exposure. Short-wavelength light is particularly effective under many experimental conditions, but circadian responses cannot be reduced to a simple distinction between blue and non-blue light.
The endogenous human circadian period averages slightly longer than 24 hours—approximately 24.2 hours in controlled laboratory studies—although individuals differ. Daily synchronization, called entrainment, ordinarily prevents the clock from drifting through the day. Light during the early biological night generally shifts the clock later, whereas light during the late biological night or biological morning generally shifts it earlier. These relationships form a phase response curve; they explain why the same exposure can have different effects at different biological times.
The pineal hormone melatonin normally rises during the biological evening under dim-light conditions. Its timing provides information about circadian phase, but it is not an on–off switch for sleep. People can sleep when melatonin concentrations are low and remain awake when concentrations are high. Circadian disorders therefore concern the relationship among internal phase, sleep pressure, and external obligations, rather than a universal deficiency or excess of one hormone.
Classification, boundaries, and population distribution
The International Classification of Sleep Disorders, third edition, published in 2014 and revised in 2023, distinguishes several circadian rhythm sleep–wake disorders according to the pattern of misalignment. Delayed and advanced sleep–wake phase disorders involve a relatively stable displacement of the major sleep episode. Non-24-hour disorder involves failure to remain synchronized to the 24-hour day. Irregular sleep–wake rhythm disorder involves a poorly consolidated pattern distributed across day and night. Shift work disorder and jet lag disorder arise principally from externally imposed schedules.
The distinction between intrinsic and extrinsic disorders is useful but incomplete. A delayed sleep pattern can reflect inherited timing tendencies, developmental changes, evening light exposure, and social reinforcement together. Conversely, two workers on the same night schedule may differ greatly in their circadian adjustment and symptoms. Classification describes the observable clinical pattern; it does not necessarily identify a single cause.
A late or early chronotype is not itself a disorder. Chronotype refers to individual differences in preferred or habitual timing of sleep and activity. Clinical classification additionally requires meaningful symptoms or impairment. Someone who sleeps comfortably from 2 a.m. to 10 a.m. and has no conflicting obligations may have an evening chronotype without a sleep disorder. The same timing can become disabling when daily attendance is required at 7 a.m. Neither clock time alone nor deviation from a population average establishes disease.
Population estimates vary substantially with definitions and sampling. Questionnaire studies may identify many people with late sleep timing, while studies requiring persistent impairment, exclusion of alternative explanations, and longitudinal documentation identify fewer cases. For this reason, estimates of eveningness, delayed sleep, and diagnosed delayed sleep–wake phase disorder are not interchangeable. Similar problems affect shift work disorder: the proportion of people working nights does not equal the proportion who develop the disorder.
Age and circumstances strongly influence distribution. Delayed patterns are especially relevant during adolescence and early adulthood, while advanced timing becomes more common with aging. Non-24-hour disorder is strongly associated with total blindness, though not all totally blind people develop it. Irregular sleep–wake rhythm disorder occurs particularly in people with neurological or neurodevelopmental conditions and in environments with weak day–night cues.
The International Classification of Diseases and psychiatric diagnostic systems also classify circadian sleep–wake conditions, but their organization and terminology do not perfectly match sleep-specialty classifications. Apparent differences in prevalence may therefore reflect coding practices, healthcare access, and diagnostic criteria as well as underlying biological differences.
Delayed and advanced sleep–wake phase disorders
Delayed sleep–wake phase disorder is characterized by a persistent delay of the main sleep episode relative to the desired or required schedule. Affected people have difficulty falling asleep at an earlier conventional bedtime and difficulty waking at the required morning time. When permitted to follow their preferred late schedule, sleep duration and quality often improve substantially. This improvement is diagnostically informative because it separates a timing problem from an inability to sleep adequately under any schedule.
A typical presentation is a person who cannot fall asleep until the early morning but must rise for school or work several hours later. Repeated forced early awakening produces sleep restriction, morning sleepiness, missed attendance, and impaired performance. On unrestricted days, sleep may extend well into late morning or afternoon. However, no particular bedtime, such as 2 a.m. or 3 a.m., universally defines the disorder; the relevant feature is a stable, impairing mismatch with required timing.
Adolescence normally brings a shift toward later circadian timing, accompanied by changes in the accumulation of sleep pressure. Evening activities and light exposure can reinforce this tendency. Clinical delayed phase nevertheless exceeds ordinary developmental variation in persistence or consequences. Familial aggregation and rare variants in clock-related genes demonstrate a biological contribution in some cases. A splice-altering variant in CRY1, reported in 2017, is one example associated with delayed sleep timing; it does not account for most cases.
Advanced sleep–wake phase disorder has the opposite pattern. Sleepiness begins unusually early in the evening, and final awakening occurs unusually early in the morning. A person may repeatedly fall asleep during evening social activities and awaken around 3 a.m. or 4 a.m., despite wishing to remain awake and asleep later. Sleep can be otherwise well consolidated when the early schedule is allowed.
Advanced timing is more frequent in older adults, but ordinary age-related morning preference is not sufficient for diagnosis. Familial forms have provided important evidence about the molecular clock. A familial advanced sleep phase phenotype was described in 1999, and a PER2 mutation associated with altered phosphorylation was reported in 2001. These findings established that changes in clock-protein regulation can shift human sleep timing.
Delayed and advanced disorders are not merely mirror images of voluntary bedtime choices. The strength of the biological tendency, environmental exposure, and capacity to maintain a socially required schedule differ between individuals. Symptoms can also become complicated by conditioned arousal, irregular recovery sleep, or coexisting insomnia, so a stable phase disorder and a separate difficulty initiating or maintaining sleep may coexist.
Non-24-hour and irregular sleep–wake rhythm disorders
Non-24-hour sleep–wake rhythm disorder occurs when the sleep–wake rhythm does not remain stably entrained to the 24-hour day. Sleep timing commonly shifts progressively later, although other patterns are possible. As the internal rhythm moves into and out of alignment with the external schedule, symptoms fluctuate. Periods of relatively satisfactory nighttime sleep alternate with periods of nighttime wakefulness and daytime sleepiness.
The disorder is particularly important in people with total blindness because retinal light input normally provides the strongest daily timing signal. Visual perception and circadian photoreception are not identical, however. Some people without conscious light perception retain retinal pathways capable of synchronizing the clock, whereas others do not. The presence or absence of useful vision therefore does not, by itself, establish whether circadian entrainment is preserved.
A simple theoretical example illustrates the drifting pattern. An unentrained clock with a period of 24.5 hours would move approximately 30 minutes later relative to civil time each day and would take about 48 days to pass through a complete 24-hour cycle. Actual sleep timing is more variable because obligations, naps, sleep pressure, and residual environmental cues influence behavior. The example describes a mechanism, not a diagnostic threshold.
Non-24-hour disorder also occurs in sighted individuals, but it is much less common and can be difficult to distinguish from severe delayed phase, highly irregular scheduling, or behaviorally maintained drift. A short recording may capture only one apparently stable interval. Extended sleep records and, in selected cases, repeated circadian phase measurements are therefore particularly important.
Irregular sleep–wake rhythm disorder differs fundamentally from a steadily drifting rhythm. There is no consistently consolidated major sleep episode; instead, several sleep bouts are distributed across the 24-hour day. Total sleep time may be broadly adequate, yet nighttime wakefulness and daytime sleep episodes create substantial impairment. The condition is not synonymous with occasional napping or an unpredictable bedtime.
Irregular rhythms are associated with dementia, some neurodevelopmental conditions, and other disorders affecting brain function. Degeneration of circadian pathways, reduced daytime illumination, low activity, and weak social scheduling may contribute in different proportions. Institutional environments can further reduce the contrast between day and night. In these settings, a fragmented rhythm may reflect both neurological disease and environmental circumstances; sleep disruption should not automatically be attributed to one mechanism.
Shift work disorder and jet lag disorder
Shift work disorder occurs when recurring work hours overlap the usual biological sleep period and produce insomnia, excessive sleepiness, or both, with reduced sleep opportunity or duration. Night work, rotating shifts, and very early starts can all create this conflict. The disorder is not defined by employment schedule alone: many shift workers experience some disruption, but clinical classification requires a persistent symptomatic relationship to the schedule.
Night work combines several challenges. The circadian system promotes sleep during part of the shift, especially near the biological temperature minimum, while daytime sleep is opposed by the circadian wake-promoting signal. Daylight during the commute and household or social demands can further shorten sleep. Some workers show partial circadian adaptation, but complete adaptation is uncommon in ordinary rotating schedules because light exposure and days off repeatedly favor a daytime orientation.
Symptoms often differ across the shift cycle. Sleepiness may be greatest toward the end of a night shift, whereas difficulty maintaining sleep may dominate after returning home. An early-morning worker can experience chronic restriction because the required wake time advances more readily than biological sleep onset. Assessment must therefore examine the actual roster, travel time, sleep opportunities, and recovery days rather than treating all nonstandard schedules as equivalent.
Jet lag disorder follows rapid travel across time zones, leaving the internal clock temporarily aligned with the departure location. Sleep disturbance, daytime sleepiness, reduced performance, and gastrointestinal symptoms can occur while different rhythms adjust at different rates. Travel fatigue from prolonged sitting, disrupted sleep, or inconvenient departure times can occur without time-zone crossing and is not the same phenomenon.
Eastward travel commonly requires a phase advance, whereas westward travel commonly requires a phase delay. Because the average human endogenous period is slightly longer than 24 hours, delaying is often easier than advancing, but direction alone does not determine severity. The number of time zones crossed, flight schedule, destination light exposure, individual circadian period, and trip duration all matter. Very large shifts can also be accomplished through different directions of biological adjustment.
Jet lag is generally transient, whereas shift work disorder reflects repeated or sustained exposure. Both demonstrate that a normally functioning clock can generate clinically important symptoms when external demands change faster than the circadian system can adjust. In occupational settings, the resulting sleepiness is relevant to patient safety, transport safety, and industrial errors. Circadian misalignment and accumulated sleep loss often occur together, making their separate contributions difficult to quantify outside controlled studies.
Clinical assessment and differential diagnosis
The core of diagnosis is a longitudinal account of sleep timing, symptoms, and external requirements. A medical history establishes habitual bedtime, estimated sleep onset, awakenings, final wake time, naps, work or school schedules, and differences between obligated and unrestricted days. The relationship between symptoms and timing is more informative than a single report of “poor sleep.” Whether sleep improves during holidays or on a freely chosen schedule is particularly useful.
Sleep diaries document the pattern prospectively. Recording commonly extends for at least one to two weeks, depending on the suspected subtype, and includes both scheduled and free days. Longer observation may be necessary for non-24-hour disorder. Diaries also record factors such as shift changes and medication timing that can explain apparent rhythm changes. A history limited to weekdays may conceal substantial recovery sleep or repeated weekend phase shifts.
Actigraphy estimates sleep and wakefulness from movement, usually through a wrist-worn device. It is useful for assessing timing across many days in ordinary environments, particularly when diary accuracy is uncertain. It does not directly measure sleep stages and can mistake quiet wakefulness for sleep. Consumer wearables vary in their algorithms and validation; their outputs are not automatically equivalent to clinical actigraphy or laboratory measurements.
Circadian phase can be assessed using dim-light melatonin onset, generally measured from serial saliva or blood samples collected under controlled low-light conditions. Core body temperature rhythms provide another physiological marker but are more cumbersome to obtain and are influenced by activity and sleep. These tests can distinguish delayed biological phase from late behavior without a comparable clock delay. They are not required in every clinical case and are not equally available across healthcare settings.
Overnight polysomnography is not usually necessary to establish a circadian timing disorder. Its main role is to investigate another suspected condition, such as obstructive sleep apnea or periodic limb movements. A single laboratory night cannot adequately characterize a rhythm that unfolds over weeks, and imposing an unfamiliar bedtime may make sleep look abnormal for reasons unrelated to the underlying diagnosis.
The differential diagnosis includes chronic insomnia, insufficient sleep, sleep-related breathing disorders, central disorders of hypersomnolence, medication effects, and substance-related sleep disruption. Depression and bipolar disorder can alter sleep timing or coexist with a circadian disorder. A reduced need for sleep during mania differs from an inability to sleep at a socially required hour. Diagnosis also requires attention to whether symptoms persist outside the suspected work schedule or timing pattern, since multiple sleep disorders can be present simultaneously.
Light, scheduling, and behavioral interventions
Nonpharmacological treatment approaches aim to change either the circadian phase, the external schedule, or the relationship between them. These are distinct objectives. Shifting the biological clock earlier is different from simply requiring an earlier bedtime, and permitting a later work start may reduce impairment without changing the underlying phase. Clinical studies therefore assess both timing and functional outcomes rather than assuming that an earlier clock time necessarily represents improvement.
Timed light exposure is a principal circadian intervention. In delayed phase disorders, protocols commonly use light after awakening to promote an earlier phase; in advanced phase disorders, evening light can promote a later phase. However, clock time is only a rough proxy for biological time. Exposure on the wrong portion of the phase response curve may produce little benefit or shift the rhythm in the opposite direction. Light studies differ in intensity, duration, timing, and accompanying behavioral changes, complicating comparisons.
Reducing light during the phase-delay portion of the evening can complement morning light exposure. The mechanism involves total retinal illumination, not merely the presence of a screen. Room lighting, outdoor conditions, viewing distance, exposure duration, and spectral properties all contribute. Laboratory demonstrations that evening light suppresses melatonin do not establish that every device or exposure pattern causes a clinical circadian disorder.
Regularity of wake time, daytime activity, meals, and social contact can strengthen environmental timing cues. Such strategies are particularly relevant when rhythms are weak or fragmented, as in some people with dementia. Their effects may involve both circadian synchronization and increased daytime wakefulness. Trials in residential care are difficult to interpret because interventions often combine brighter daytime light, exercise, staff changes, and structured routines.
For shift work, interventions may alter light exposure, sleep opportunities, or the roster itself. Planned sleep periods and scheduled naps primarily address sleep loss and acute sleepiness; they do not necessarily reset the clock. Workplace approaches operate at the level of public health and occupational organization as well as individual behavior. No single shift pattern eliminates the biological conflict for every worker.
A historically used method called chronotherapy progressively moves sleep around the clock, often by repeated delays, until the desired schedule is reached. Evidence is limited, maintaining the resulting schedule can be difficult, and persistent free-running patterns have been reported after its use. Cognitive behavioral therapy can address conditioned insomnia or beliefs and behaviors that perpetuate sleep difficulty, but it is conceptually different from a treatment that directly shifts circadian phase.
Melatonin, other medicines, and strength of evidence
Exogenous melatonin has two relevant actions: it can influence sleep propensity and can shift circadian timing. These actions depend differently on dose, formulation, and administration time. A dose taken near bedtime may have a sleep-promoting effect, while a dose taken earlier in the biological evening may produce a phase advance. Larger doses are not necessarily more effective at resetting the clock because prolonged exposure can extend across different portions of the melatonin phase response curve.
The American Academy of Sleep Medicine's 2015 guideline supported strategically timed melatonin for selected intrinsic circadian disorders, including delayed sleep–wake phase disorder in adults and non-24-hour disorder in blind adults. Its recommendations were generally weak, reflecting limitations in the available trials. The same guideline supported selected light-based approaches for particular populations rather than endorsing a universal protocol. A weak recommendation indicates uncertainty in evidence or the balance of effects; it does not mean that every patient experiences only a small benefit.
A 2018 randomized controlled trial in adults with delayed sleep–wake phase disorder and delayed melatonin timing examined low-dose melatonin alongside a behavioral sleep–wake schedule. It found improvements in sleep initiation and related outcomes compared with placebo alongside the same scheduling intervention. Such findings apply to the studied population and protocol; they do not establish that all people with late bedtimes have a melatonin-responsive circadian disorder.
Tasimelteon, a melatonin-receptor agonist, received United States approval in 2014 for non-24-hour sleep–wake disorder in adults. Its pivotal trials involved totally blind adults and assessed entrainment as well as sleep-related outcomes. Entrainment was not achieved by every participant, and maintaining synchronization depended on continued treatment. Regulatory indications and available formulations vary between jurisdictions, so approval in one setting does not establish universal use across all circadian disorders.
Wake-promoting medicines have been studied and approved in some jurisdictions for excessive sleepiness associated with shift work disorder. Their principal action is symptomatic: increased alertness does not necessarily mean that the circadian system has adapted or that sleep debt has been corrected. Similarly, sedative medicines may facilitate sleep without restoring appropriate circadian alignment. Studies must distinguish symptom suppression from changes in the underlying rhythm.
Evidence interpretation also depends on product quality and study design. Melatonin supplements can differ from pharmaceutical preparations in content and release characteristics. Trials often combine medication with prescribed scheduling, making the independent contribution of each component difficult to determine. Outcomes such as sleep-onset time, total sleep duration, circadian phase, daytime functioning, and adverse effects address different clinical questions and should not be treated as interchangeable measures of success.
Functional consequences, associated illness, and research priorities
The most immediate consequences are impaired alertness, reduced concentration, attendance difficulties, and disruption of social and family life. The burden can be substantial even when sleep is normal on an unrestricted schedule. A person whose biological night extends into the school or workday may repeatedly lose sleep while attempting to meet obligations, creating both circadian misalignment and chronic sleep restriction. These mechanisms overlap but are not identical.
Mood symptoms frequently accompany circadian sleep–wake disturbance. Associations with depression and other mental health conditions are well documented, but causal direction varies. A delayed rhythm can interfere with daytime participation, mood disorders can alter activity and light exposure, and shared biological factors may influence both. Observational coexistence does not establish that a timing disorder is the sole cause of psychiatric symptoms or that correcting sleep phase will resolve another disorder.
Long-term shift work has been associated in observational studies with cardiometabolic outcomes, including type 2 diabetes and cardiovascular disease. These findings are relevant to circadian biology but cannot simply be transferred to every intrinsic circadian disorder. Shift workers also differ in sleep duration, meal timing, occupational exposures, socioeconomic circumstances, and other characteristics. Statistical adjustment reduces some confounding but does not make observational associations equivalent to experimental proof of causation.
Laboratory studies provide complementary evidence. Forced-desynchrony protocols schedule sleep and wakefulness on a cycle to which the circadian system cannot readily entrain. Researchers can then separate effects of biological time from effects of time awake. Such experiments demonstrate independent circadian influences on sleep propensity, performance, and metabolic responses. Their controlled conditions, however, differ from the variable light, activity, and scheduling encountered over years of ordinary life.
A major research problem is heterogeneity within diagnostic labels. People classified as having delayed sleep–wake phase disorder may differ in endogenous phase, circadian period, light sensitivity, sleep-pressure dynamics, and behavioral reinforcement. Measuring a biomarker such as melatonin timing can identify biologically distinct patterns, but testing adds cost and requires standardized conditions. Studies continue to examine whether this additional information reliably improves treatment selection and outcomes.
Clinical trials also face practical obstacles: blinding light interventions is difficult, adherence to precisely timed schedules varies, and participants' school or work obligations may change during follow-up. Long-term functioning and health-related quality of life are less consistently measured than sleep timing. Current research consequently includes personalized timing models, improved ambulatory phase estimation, and interventions adapted to realistic environments, with particular attention to children, older adults, blind people, and workers whose schedules cannot easily be changed.